Genelex Corporation

Author： Coleman Howard   Ashcraft Kristine  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.4, 2008-04, pp. : 469-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gentris Corporation

By Crean Jennifer  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 148-150

Future Medicine

Access to resources Recommend Favorite

Tramadol – Biovail Corporation

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 182-183

Adis International

Access to resources Recommend Favorite

CuraGen Corporation

By Mansfield Traci   Vincent Mark R  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 551-554

Future Medicine

Access to resources Recommend Favorite

Morphine Oral - Elan Corporation: Avinza™

By  

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 208-209

Adis International

Access to resources Recommend Favorite

Alpha-Antitrypsin - Alpha Therapeutic Corporation: AAT - Alpha Therapeutic Corporation, Alpha-1 Proteinase Inhibitor - Alpha Therapeutic Corporation, Alpha-1-Antitrypsin - Alpha Therapeutic Corporation, Aralast™, Respitin™

By  

Drugs in R&D, Vol. 4, Iss. 2, 2003-01 ,pp. : 113-114

Adis International

Access to resources Recommend Favorite